Chris Hogg is a digital health advocate interested in how new forms of health data are changing the relationship between physician and patient. As CCO of Propeller Health, he leads the company’s San Francisco office and oversees the pharma BD, health system and payer sales, clinical and medical affairs and data science teams. Prior to Propeller Health he co-founded 100Plus, a mobile health company using personalized analytics to promote healthy behaviors, which was acquired by Practice Fusion in 2013. At Practice Fusion he built a data science group that created data products leveraging the company’s 80+ million patient clinical database. Prior to 100Plus Chris led the Cardiovascular Commercial Strategy group at Gilead Sciences. Chris holds a Degree in Molecular and Cell Biology from Brown University and an MBA from The University of Chicago.
DTx, defined as software-driven evidence-based therapeutic medical interventions, are used increasingly for conditions not well-addressed by mainstream medicine. These therapies collect information on a new frontier: a patient’s moment-by-moment physiological processes, emotions, behaviors, and environment. How should these highly personalized tools be implemented? How should this flood of data be governed and analyzed? How will the increased information affect the provider’s role? A panel of DTx developers will address these questions and more.